Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level

Journal of Psychiatric Research

Volumn 46, Issue 9, 2012, Pages 1118-1125

  Elfving, Betina ^a   Buttenschøn, Henriette N ^a   Foldager, Leslie ^a,b   Poulsen, Pia H P ^a   Andersen, Johan H ^c   Grynderup, Matias B ^a   Hansen, Åse M ^d   Kolstad, Henrik A ^a   Kaerlev, Linda ^a,e   Mikkelsen, Sigurd ^f   Thomsen, Jane F ^f   Børglum, Anders D ^a,b   Wegener, Gregers ^a   Mors, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c HERNING HOSPITAL   (Denmark)

^d National Research Centre for the Work Environment   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Association; Brain derived neurotrophic factor (BDNF); Depression; Serum; Single nucleotide polymorphism (SNP); Val66Met

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC MARKER; GENOTYPE; GROUPS BY AGE; HUMAN; INTRON; LIFESTYLE; MALE; MISSENSE MUTATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84864380929     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.05.003     Document Type: Article

References (54)

1. Alonso J., Angermeyer M.C., Bernert S., Bruffaerts R., Brugha T.S., Bryson H., et al. Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Supplementum 2004, 21-27.
2. Aydemir C., Yalcin E.S., Aksaray S., Kisa C., Yildirim S.G., Uzbay T., et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Progress in Neuropsychopharmacology and Biological Psychiatry 2006, 30:1256-1260.
3. Aydemir O., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progress in Neuropsychopharmacology and Biological Psychiatry 2005, 29:261-265.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology 2008, 11:1169-1180.
6. Bus B.A., Molendijk M.L., Penninx B.J., Buitelaar J.K., Kenis G., Prickaerts J., et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011, 36:228-239.
7. Bus B.A., Tendolkar I., Franke B., de G.J., Heijer M.D., Buitelaar J.K., et al. Serum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World Journal of Biological Psychiatry 2011, 10.3109/15622975.2010.545187.
8. Buttenschøn H.N., Kristensen A.S., Buch H.N., Andersen J.H., Bonde J.P., Grynderup M., et al. The norepinephrine transporter gene is a candidate gene for panic disorder. Journal of Neural Transmission 2011, 118:969-976.
9. Castren E., Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010, 70:289-297.
10. Cattaneo A., Bocchio-Chiavetto L., Zanardini R., Milanesi E., Placentino A., Gennarelli M. Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. International Journal of Neuropsychopharmacology 2010, 13:103-108.
11. Chan K.L., Tong K.Y., Yip S.P. Relationship of serum brain-derived neurotrophic factor (BDNF) and health-related lifestyle in healthy human subjects. Neuroscience Letters 2008, 447:124-128.
12. Chen L., Lawlor D.A., Lewis S.J., Yuan W., Abdollahi M.R., Timpson N.J., et al. Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:814-821.
13. Currie J., Ramsbottom R., Ludlow H., Nevill A., Gilder M. Cardio-respiratory fitness, habitual physical activity and serum brain derived neurotrophic factor (BDNF) in men and women. Neuroscience Letters 2009, 451:152-155.
14. Curtis D., Vine A.E., Knight J. A simple method for assesing the strength of evidence for assocation at the level of whole gene. Advances and Applications in Bioinformatics and Chemistry 2008, 1:115-120.
15. Duman R.S. Synaptic plasticity and mood disorders. Molecular Psychiatry 2002, 7(Suppl. 1):S29-S34.
16. Duncan L.E., Hutchison K.E., Carey G., Craighead W.E. Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. Journal of Affective Disorders 2009, 115:215-219.
17. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
18. Elfving B., Plougmann P.H., Müller H.K., Mathé A.A., Rosenberg R., Wegener G. Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. International Journal of Neuropsychopharmacology 2010, 13:563-572.
19. Elfving B., Plougmann P.H., Wegener G. Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. Journal of Neuroscience Methods 2010, 187:73-77.
20. Gama C.S., Andreazza A.C., Kunz M., Berk M., Belmonte-de-Abreu P.S., Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neuroscience Letters 2007, 420:45-48.
21. Gass P., Hellweg R. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders?. International Journal of Neuropsychopharmacology 2010, 13:1-4.
22. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 2005, 255:381-386.
23. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry 2011, 16:960-972.
24. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 2003, 23:6690-6694.
25. Kaerlev L., Kolstad H.A., Hansen A.M., Thomsen J.F., Kaergaard A., Rugulies R., et al. Are risk estimates biased in follow-up studies of psychosocial factors with low base-line participation?. BMC Public Health 2011, 11:539.
26. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 2002, 109:143-148.
27. Kolstad H.A., Hansen A.M., Kaergaard A., Thomsen J.F., Kaerlev L., Mikkelsen S., et al. Job strain and the risk of depression: is reporting biased?. American Journal of Epidemiology 2011, 173:94-102.
28. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35:744-759.
29. Lee B.H., Kim Y.K. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology 2009, 59:51-58.
30. Licinio J., Dong C., Wong M.L. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Archives of General Psychiatry 2009, 66:488-497.
31. Lu B., Pang P.T., Woo N.H. The yin and yang of neurotrophin action. Nature Reviews Neuroscience 2005, 6:603-614.
32. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 2009, 24:27-53.
33. Molendijk M.L., Bus B.A., Spinhoven P., Penninx B.W., Kenis G., Prickaerts J., et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Molecular Psychiatry 2011, 16:1088-1095.
34. Nakazato M., Hashimoto K., Shimizu E., Kumakiri C., Koizumi H., Okamura N., et al. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biological Psychiatry 2003, 54:485-490.
35. Nyegaard M., Demontis D., Foldager L., Hedemand A., Flint T.J., Sorensen K.M., et al. CACNA1C (rs1006737) is associated with schizophrenia. Molecular Psychiatry 2010, 15:119-121.
36. Ozan E., Okur H., Eker C., Eker O.D., Gonul A.S., Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Research Bulletin 2010, 81:61-65.
37. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
38. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
39. Reis H.J., Nicolato R., Barbosa I.G., Teixeira do Prado P.H., Romano-Silva M.A., Teixeira A.L. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neuroscience Letters 2008, 439:157-159.
40. Sartorius A., Hellweg R., Litzke J., Vogt M., Dormann C., Vollmayr B., et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270-276.
41. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biological Psychiatry 2005, 58:307-314.
42. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008, 64:527-532.
43. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 2003, 54:70-75.
44. Suchanek R., Owczarek A., Kowalczyk M., Kucia K., Kowalski J. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population. Journal of Molecular Neuroscience 2011, 43:524-530.
45. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 2000, 157:1552-1562.
46. Sun R.F., Zhu Y.S., Kuang W.J., Liu Y., Li S.B. The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia. Neuroscience Letters 2011, 489:34-37.
47. Tang S.W., Chu E., Hui T., Helmeste D., Law C. Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neuroscience Letters 2008, 431:62-65.
48. Terracciano A., Lobina M., Piras M.G., Mulas A., Cannas A., Meirelles O., et al. Neuroticism, depressive symptoms, and serum BDNF. Psychosomatic Medicine 2011, 73:638-642.
49. Umene-Nakano W., Yoshimura R., Ikenouchi-Sugita A., Hori H., Hayashi K., Ueda N., et al. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence. Human Psychopharmacology 2009, 24:409-413.
50. Umene-Nakano W., Yoshimura R., Yoshii C., Hoshuyama T., Hayashi K., Hori H., et al. Varenicline does not increase serum BDNF levels in patients with nicotine dependence. Human Psychopharmacology 2010, 25:276-279.
51. Verhagen M., van der M.A., van Deurzen P.A., Janzing J.G., rias-Vasquez A., Buitelaar J.K., et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 2010, 15:260-271.
52. World Health Organization Diagnosis and clinical measurement in psychiatry 1998, A Reference Manual for SCAN.
53. World Health Organization G The ICD10 classification of mental and behavioural disorders. Diagnostic Criteria for Research 1993.
54. Yoshimura R., Kish T., Suzuki A., Umene-Nakano W., Ikenouchi-Sugita A., Hori H., et al. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Progress in Neuropsychopharmacology and Biological Psychiatry 2011, 35:1022-1025.